LoginRegister
    Alembic Pharma gets tentative USFDA nod for Bimatoprost Ophthalmic SolutionAlembic Pharma gets tentative USFDA nod for Bimatoprost Ophthalmic Solution
    Meril Life Sciences gets European Conformity mark for Bioresorbable Scaffold MeRes100Meril Life Sciences gets European Conformity mark for Bioresorbable Scaffold MeRes100
    Lupin net profit rises 49.46 percent to Rs 303 crore for June quarterLupin net profit rises 49.46 percent to Rs 303 crore for June quarter
    Knew about Zolgensma data problems before US approval: NovartisKnew about Zolgensma data problems before US approval: Novartis
    Bayer buys BlueRock in USD 600 million bet on stem cell therapiesBayer buys BlueRock in USD 600 million bet on stem cell therapies
    Bayer Rivaroxaban tablets win CDSCO Committee nod for waiver of local clinical trial; directed to carry Phase IV trialBayer Rivaroxaban tablets win CDSCO Committee nod for waiver of local clinical trial; directed to...
    Cadila Healthcare gets OAI letter from USFDA for Moraiya facilityCadila Healthcare gets OAI letter from USFDA for Moraiya facility
    Aurobindo Pharma Q1 net profit up by 39.52 percent to Rs 636 croreAurobindo Pharma Q1 net profit up by 39.52 percent to Rs 636 crore
    GSK ends Ebola vaccine RnD; transfers license to US instituteGSK ends Ebola vaccine RnD; transfers license to US institute
    Novartis concealed data problem before seeking approval for USD 2.1 million gene therapy Zolgensma: USFDANovartis concealed data problem before seeking approval for USD 2.1 million gene therapy Zolgensma:...
    Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice PresidentParas Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President
    Price Cap: NLEM Committe to now target intraocular lens, dialysis fluid, hearing aids;Price Cap: NLEM Committe to now target intraocular lens, dialysis fluid, hearing aids;
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X